Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
4.160
+0.210 (5.32%)
At close: May 29, 2025, 4:00 PM
4.250
+0.090 (2.16%)
After-hours: May 29, 2025, 6:10 PM EDT
Rezolute Market Cap
Rezolute has a market cap or net worth of $251.83 million as of May 29, 2025. Its market cap has increased by 112.51% in one year.
Market Cap
251.83M
Enterprise Value
161.26M
1-Year Change
112.51%
Ranking
Category
Stock Price
$4.16
Market Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $251.83M, an increase of 50.79%. That is a compound annual growth rate of 9.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2025 | 337.80M | 18.99% |
| Dec 31, 2024 | 283.90M | 622.39% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 645.82B |
| Johnson & Johnson | 366.76B |
| AbbVie | 323.41B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 270.43B |
| Abbott Laboratories | 229.69B |
| Novartis AG | 219.70B |
| AstraZeneca | 216.88B |